Page last updated: 2024-08-24

baicalin and Multiple Sclerosis

baicalin has been researched along with Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ciric, B; Gran, B; Li, X; Ma, CG; Rostami, A; Zhang, GX; Zhang, Y	1

Other Studies

1 other study(ies) available for baicalin and Multiple Sclerosis

Article	Year
Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway. Scientific reports, 2015, Nov-30, Volume: 5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Flavonoids; Inflammation Mediators; Lymphocyte Activation; Mice; Multiple Sclerosis; NF-kappa B; Signal Transduction; STAT Transcription Factors; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; T-Lymphocyte Subsets; Th1 Cells; Th17 Cells	2015

Article

Year

Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.

Scientific reports, 2015, Nov-30, Volume: 5

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Flavonoids; Inflammation Mediators; Lymphocyte Activation; Mice; Multiple Sclerosis; NF-kappa B; Signal Transduction; STAT Transcription Factors; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; T-Lymphocyte Subsets; Th1 Cells; Th17 Cells

2015